Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet

Clinical trial NCT03074058 · COMPLETED

Trial details

NCT number: NCT03074058
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical Pharmacology

Start date: 2015-06-10
Primary completion: 2015-08-04
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.